Instalab
logoInstalab

Dog (Can f 4) IgE

Blood Test
A blood signal of true dog allergy, beyond what whole dander tests can tell you.
4.8 (4,174 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Dog (Can f 4) IgE test?

This test is most useful if any of these apply to you.

Reacting Around Dogs
If sneezing, wheezing, or itchy eyes show up around dogs, this test helps confirm whether your body is mounting a true allergic response.
Managing Stubborn Asthma
If your asthma flares unpredictably, dog lipocalin sensitization is linked to greater severity and may be a hidden trigger worth identifying.
Living with Atopic Dermatitis
Higher IgE to dog lipocalins tracks with more severe eczema and overlapping asthma or rhinitis, making this a useful piece of your atopic profile.
Considering Allergy Immunotherapy
If you are weighing allergen immunotherapy, knowing your component pattern helps your allergist decide whether and how to treat your dog allergy.

About Dog (Can f 4) IgE

If you sneeze, wheeze, or break out around dogs, the question is not just whether you are allergic, but which specific dog protein your immune system is targeting. Standard dog dander tests lump every dog allergen together, which can leave you with a positive result and no clear sense of how severe your reaction is likely to be.

Testing your blood for IgE (immunoglobulin E, the antibody class that drives allergic reactions) against Can f 4, a specific dog protein, gives a sharper read. People who react to Can f 4 and similar dog proteins called lipocalins tend to have more genuine, more severe dog allergy than people sensitized to other dog molecules.

What Can f 4 Actually Is

Can f 4 is one of several individual dog proteins (called components) that can trigger allergic reactions. It belongs to a family of dog molecules known as lipocalins. Can f 4 was originally purified from dog dander extract and has been described as a dominating allergen in fur samples, while studies analyzing dog saliva specifically have not identified Can f 4 there. Your blood test measures whether your immune system has built IgE antibodies that specifically recognize Can f 4.

Component-resolved testing like this is more refined than older tests that use a crude mix of all dog proteins. Instead of telling you only that you react to something in dogs, it tells you which protein you react to, which carries different clinical meaning.

How Often Dog-Allergic People Have Can f 4 IgE

Sensitization to Can f 4 is common among dog-allergic people, though the exact percentage depends on the population and the test used. In one published practice parameter, around 35 percent of dog-allergic patients had IgE to recombinant Can f 4. Other studies using purified natural Can f 4 have reported substantially higher rates of detection.

In a Korean cohort of adults sensitized to dog or cat dander, a meaningful share had Can f 4 IgE at or above the detection threshold. The differences across studies reflect both the underlying populations and the lab method, since Can f 4 binding depends heavily on the molecule keeping its proper three-dimensional shape during testing. Natural and recombinant forms can yield different detection rates.

Confirming Real Dog Allergy

The most actionable finding in this research is that Can f 4 IgE strongly predicts an objective allergic reaction to dog exposure. In children sensitized to dog dander, having IgE to Can f 4 was associated with about a seven-fold higher odds of a positive nasal challenge test (odds ratio 6.80, 95% confidence interval 1.84 to 25.2), where dog allergen is placed directly in the nose to see if symptoms result.

This matters because many people have a positive result on a generic dog allergy test but no real symptoms when exposed. A positive Can f 4 result helps confirm that your body actually mounts a meaningful allergic response, not just a paper one. The more dog components you react to, the higher the chance of real-world symptoms on exposure.

Asthma and Respiratory Severity

Dog lipocalin sensitization is not just about sneezing. In children with dog dander allergy, those with troublesome asthma had higher IgE levels to Can f 2, Can f 4, and Can f 6 than other dog-sensitized children. This pattern of sensitization to multiple lipocalins tracks with asthma morbidity and severity, and multi-sensitization to lipocalins, kallikreins, and secretoglobins has been linked to increased bronchial inflammation in severe childhood asthma.

In a study of 19-year-olds in northern Sweden, high-titer IgE to cat and dog allergens was strongly associated with asthma diagnosis, severity, and persistence, even when participants did not currently live with a pet. The signal was strong enough to suggest that simply removing exposure does not erase the underlying allergic biology.

Atopic Dermatitis Connections

In a study of 100 atopic dermatitis patients using a broad multiplex IgE test, higher levels of IgE to several dog lipocalins, including Can f 4, were associated with greater eczema severity and with co-existing asthma and allergic rhinitis. The pattern of dog component sensitization reflects something deeper than skin or nose symptoms alone, often pointing to a more reactive immune phenotype overall.

Diagnostic Performance Compared with Standard Tests

Whole-dog-dander IgE testing on its own produces moderate diagnostic performance, with sensitivity and specificity that vary across studies. Skin prick testing to dog generally performs comparably to or worse than blood IgE in head-to-head comparisons depending on the population.

Can f 4 is not used as a standalone diagnostic with its own cutpoints. Instead, it adds resolution to the broader dog component panel. When you combine Can f 1, Can f 5, Can f 4, and other components, you get a more reliable picture of dog allergy than dander extract alone, and you can better separate true clinical dog allergy from purely lab-only sensitization.

Tracking Your Trend

Allergen-specific IgE is not a one-and-done test. Levels can rise with repeated exposure, fall with avoidance, and change substantially with treatment over months to years. A single number tells you about the moment of the blood draw. A trend tells you whether your immune system is becoming more reactive, holding steady, or quieting down.

If you are starting allergen immunotherapy or a biologic medication that targets allergy pathways, retesting after several months and again at one or two years gives you a meaningful read on whether the treatment is reshaping the underlying biology. If you are simply monitoring a known sensitization, an annual check is reasonable, with more frequent testing if your symptoms change noticeably or you alter your exposure.

When Results Can Be Misleading

A few things can complicate interpretation of a Can f 4 IgE result. The most important ones to know:

  • Assay method matters: Can f 4 binding depends on the molecule keeping its proper three-dimensional structure. Purified natural Can f 4 tends to detect IgE in a higher share of dog-allergic patients than some recombinant forms. Results between labs are not always interchangeable.
  • Sensitization is not the same as allergy: A positive Can f 4 IgE means your immune system recognizes the protein. It does not always mean you will have symptoms on dog exposure. The clinical picture, often confirmed with a provocation test, is what determines true allergy.
  • Cross-reactivity with other furry animals: Lipocalins and serum albumins are shared across cats, dogs, and other mammals. In one study, about 48 percent of dog sensitizations appeared to result from cross-reactivity with cat. A positive result may reflect cross-reactivity rather than pure dog-specific sensitization, especially if you have IgE to multiple animal components.
  • Active immunotherapy or dupilumab use: Allergen immunotherapy initially raises specific IgE before lowering it over time. The biologic dupilumab can suppress allergen-specific IgE to aeroallergens including animal dander over months of treatment. If you are on these therapies, interpret single readings in the context of treatment timing.

What to Do with an Unexpected Result

If you test positive for Can f 4 IgE and you do have symptoms around dogs, the next step is usually to order or review the rest of the dog component panel (Can f 1, 2, 3, 5, and 6) and a cat component panel, because polysensitization patterns predict symptom risk better than any single result. An allergist can interpret the pattern alongside your history and decide whether allergen immunotherapy or other targeted treatment makes sense.

If you test positive but feel fine around dogs, you may have sensitization without clinical allergy. This is still worth knowing, especially if you are considering adopting a dog or if your symptoms shift later. A positive result alongside asthma or atopic dermatitis is worth flagging to your clinician, since the pattern points to a more reactive overall allergic phenotype. If results are isolated and confusing, retesting in a few months with the same lab can confirm whether the finding is stable.

What Moves This Biomarker

Evidence-backed interventions that affect your Dog (Can f 4) IgE level

↕ Up & Down
Allergen immunotherapy with cat and dog dander extracts
If you start dog dander immunotherapy, specific IgE typically rises in the first months before falling over one to two years, while protective IgG4 antibodies climb substantially. In trials of patients on cat or dog dander extract, this pattern coincided with reduced asthma symptoms and skin reactivity. The early IgE rise is expected and does not mean treatment is failing.
MedicationStrong Evidence
↓ Decrease
Dupilumab (an IL-4 and IL-13 blocking biologic)
If you take dupilumab for allergic rhinitis or related conditions, your allergen-specific IgE to perennial allergens including animal dander declines substantially (roughly 55 to 89 percent in published reports) over months of treatment, alongside reduced total IgE and symptom improvement. This is a deliberate immune-modifying effect, not a testing artifact, and reflects real change in the underlying allergic biology.
MedicationStrong Evidence

Frequently Asked Questions

References

11 studies
  1. Ronka AL, Kinnunen TT, Goudet a, Rytkonen-nissinen M, Virtanen TThe Journal of Allergy and Clinical Immunology2015
  2. Niemi MH, Rytkonen-nissinen M, Janis J, Virtanen T, Rouvinen JMolecular Immunology2014
  3. Portnoy J, Kennedy K, Sublett JAnnals of Allergy, Asthma & Immunology2012
  4. Kack U, Asarnoj a, Gronlund H, Borres M, Van Hage M, Lilja G, Konradsen JThe Journal of Allergy and Clinical Immunology2018